Alcoholic liver disease

Similar documents
Intracellular fat deposition

The Polyphenol Study. Effect of Dietary Polyphenols on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome

NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center

Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ

Alcohol and the Liver

Non-alcoholic fatty liver disease: Prognosis and Treatment

Conveners: S. Bruno, C.M. Mastroianni

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care

Boehringer Ingelheim- sponsored Satellite Symposium. HCV Beyond the Liver

New Approaches to Treating Fatty Liver Disease. Mack C. Mitchell, MD University of Texas Southwestern Medical Center Dallas, Texas

Is Insulin Effecting Your Weight Loss and Your Health?

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

The Diabetes Epidemic

GloP1r - A New Frontier in Exercise and Nutrition

Give a NOD to diabetes:

Abnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London

Liver, Gallbladder, Exocrine Pancreas KNH 406

Viral Liver Disease. The Liver and Its Functions

Introduction. Pathogenesis of type 2 diabetes

THE FAT YOU CAN T SEE

CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

Nonalcoholic Fatty Liver Disease. Dietary and Lifestyle Guidelines

Are You Afraid of Fat?

Diabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke

METABOLIC SYNDROME. Rebecca Rovay-Hazelton, Licensed Nutritionist

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

BEST & WORST FOODS FOR BELLY FAT

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points

DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE

Beating insulin resistance through lifestyle changes

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

Nutrients: Carbohydrates, Proteins, and Fats. Chapter 5 Lesson 2

SHAHID AZIZ DO, FACOI.

Patterns of abnormal LFTs and their differential diagnosis

Antioxidant response in patients with chronic hepatitis B or C.

Cardiovascular Disease Risk Factors

How To Get Healthy

Sinclair Community College, Division of Allied Health Technologies

Dietary Fiber and Alcohol. Nana Gletsu Miller, PhD Spring 2014

The Skinny on Visceral Fat

ARTICLE #1 PLEASE RETURN AT THE END OF THE HOUR

Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007

An Investigation of Alcohol Metabolizing Enzyme Genes in Chinese Alcoholics With Pancreatitis,, Cirrhosis of Liver, and Avascular Necrosis of Hip

Do You Know the Health Risks of Being Overweight?

Risk Factors for Alcoholism among Taiwanese Aborigines

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases

Non-Alcoholic Fatty Liver Disease

BURDEN OF LIVER DISEASE IN BRAZIL

Epidemiology of Hypertension 陈 奕 希 李 禾 园 王 卓

LA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti. Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova

MANAGEMENT OF LIVER CIRRHOSIS

A link between gut microbiota, mucosal immunity and autoimmune arthritis. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

Chapter 3 Type 1 Diabetes

DR. Trinh Thi Kim Hue

Autoimmunity and immunemediated. FOCiS. Lecture outline

Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health

Inhaled Corticosteroids and Diabetes Onset

Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome

Food Allergy Gluten & Diabetes Dr Gary Deed Mediwell 314 Old Cleveland Road Coorparoo

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Cholesterol and Triglycerides What You Should Know

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic

Triglycerides: Frequently Asked Questions

Diabetes. Patient Education. What you need to know. Diabetes Facts. Improving Health Through Education. What is Diabetes?

DIABETES & HEALTHY EATING

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

What You Don t Know Can Harm You

NUTRITION IN LIVER DISEASES

Genetics BRCA1 and BRCA2 are gene mutations which give 5 percent genetic risk of breast and ovary cancers. Worse if they drink alcohol.

Greater Risk of Ascitic Cirrhosis in Females in Relation to Alcohol Consumption

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Diabetes and Obesity. The diabesity epidemic

A Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011

Overview. Nutritional Aspects of Primary Biliary Cirrhosis. How does the liver affect nutritional status?

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

The Mediterranean Diet (Monterey Style)

TERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES. Definitions for Common Terms Related to Type 2 Diabetes

Blood clot in atheroma. help make vitamin D and hormones, like oestrogen and testosterone, in your body.

Improving cardiometabolic health in Major Mental Illness

Cardiology Department and Center for Research and Prevention of Atherosclerosis, Hadassah Hebrew University Medical Center.

Mediterranean diet: A heart-healthy eating plan Source: mayoclinic.org/mediterranean-diet

Introduction To The Zone

Update on Hepatitis C. Sally Williams MD

Causes, incidence, and risk factors

Cholesterol made simple!

Diabetes and Aboriginal Canadians

Alcohol Related Harm in India. a fact sheet

Alcohol: The good, the bad and

AmphoraNet: Taxonomic Composition Analysis of Metagenomic Shotgun Sequencing Data

Clinical Nutrition and Dietetics Papers are given with Subject paper code A.

Non-alcoholic Fatty Liver Disease (NAFLD): Does Anything Help?

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

7 Ways Your DNA Influences Your Ability to Lose Weight

Booklet B The Menace of Alcohol

Eat Well, Live Well Lesson 9: The Lowdown on Cholesterol

Transcription:

Maladie alcoolique et non alcoolique du foie La place des facteurs génétiques et environnementaux Alcoholic liver disease Healty liver Fatty liver Cirrhosis HCC 13 ème Journée d automne d actualités en Gastro-entérologie et Hépatologie Pierre Deltenre Service de Gastro-entérologie et d'hépatologie CHUV pierre.deltenre@chuv.ch 90 100% 10 30% 1 2% /an Excessive alcohol consumption per se is not sufficient to induce ALD Relationship between the amount of alcohol and the likelihood of developing ALD Italia - 6,534 subjects followed for up to 60 years Meta-analysis RR associated with alcohol intake 25 g/day RR: 2.9 (95% CI: 2.7-3.1) Bellentani S, et al. Gut 1997;41:845-50 Corrao G, et al. Prev Med 2004;38:613-19 1

Meta-analysis dose of alcohol and risk of cirrhosis Relative risk and meta-regression curve of liver cirrhosis associated with alcohol consumption Women Men Meta-analysis dose of alcohol and risk of cirrhosis Women Mortality Liver cirrhosis RR P-value RR P-value 0-12 g/d 1.9 0.013 0.4 0.105 12-24 g/d 5.6 < 0.001 1.0 0.981 24-36 g/d 7.7 < 0.001 2.4 < 0.001 Men 0-12 g/d 1.0 0.991 0.3 12-24 g/d 1.6 < 0.001 0.3 < 0.001 24-36 g/d 2.8 < 0.001 0.7 0.029 36-48 g/d 5.6 < 0.001 2.0 < 0.001 Rehm J, et al. Drug Alcohol Rev 2010;29:437-45 Lifetime abstainers were the reference group Rehm J, et al. Drug Alcohol Rev 2010;29:437-45 Good or bad alcohol? Danish supermarket survey 3,500,000 transactions Wine buyers more olives, fruit or vegetables, poultry, cooking oil, and low fat products Beer buyers more ready cooked dishes, sugar, cold cuts, chips, pork, butter, sausages, lamb, and soft drinks Full of fructose which is related to the risk of fibrosis in NAFLD Johansen D, et al. BMJ 2006;332:519-22 ALD: the role of overweight % 18 16 14 12 10 8 6 4 2 0 Steatosis AH Cirrhosis 1604 heavy drinkers with a liver biopsy Overweight 10 years: BMI >25 BMI >27 2.15 times increase risk of cirrhosis in overweight patients Overweight Non overweight Naveau S, et al. Hepatology 1997;25:108-11 2

Standardized rates for liver cirrhosis over 5 years by BMI and alcohol consumption Scotland - 1,230,662 women followed for 6.2 years Relative risks of contributions of BMI and alcohol to liver disease mortality England and Scotland - 9,559 men followed for 29 years Incidence of liver cirrhosis SYNERGIC EFFECT Liver disease mortality SYNERGIC EFFECT Liu B, et al. BMJ 2010;340:912 Adjusted for all risk factors Hart CL, et al. BMJ 2010;340:1240 Independent risk factors for mortality in ALD US - 15,886 participants followed for 13.3 years (235 patients with ALD) Individuals with ALD and components of MS (type 2 diabetes, IR or elevated BMI) are at higher risk of mortality and/or liver-related mortality Stepanova M, et al. Gut 2010;59:1410-15 Lines of evidences for a genetic background in ALD Women are more susceptible to ALD following the consumption of similar amounts of alcohol Hispanic subjects are more prone to developing ALD than black and white subjects Monozygotic twins have a higher prevalence of alcoholic cirrhosis than dizygotic twins Stickel F and Hampe J. Gut 2011;61:150-59 Numerous candidate genes in ALD Alcohol metabolism Oxydative stress Immune reactions Fibrosis Steatosis PNPLA3: The strongest association 3

PNPLA3 = Patatin-like phospholipase domain-containing protein 3 PNPLA3 and ALD Triglycerides PNPLA3 Substitution of CG/GG C allele G P Remplacement Isoleucine Méthionine (position 148) Active site Product FIBROSIS Enzyme-substrate complex Peroxidation Inflammation Patients with ALC as cases are compared with alcoholics without liver disease (a) GG vs. CC genotypes (b) GC vs. CC genotypes He et al, J Biol Chem 2010;285:6706-15 Chamorro AJ, et al. APT, in press PNPLA3 and NAFLD PNPLA3 and HCC Sookoian S, et al. Hepatology 2011;53:1883-94 Trépo E, et al. Hepatology 2014;59:2170-77 Our other genome Gut microbiota The collection of microorganisms that live in peaceful coexistence with their hosts has been referred to as the microbiota, microflora, or normal flora It is estimated that the human microbiota contains as many as 10 14 bacterial cells, a number that is 10 times greater than the number of human cells present in our bodies The colon alone is estimated to contain over 70% of all the microbes in the human body The human gut microbiota is dominated by only 2 phyla : the Bacteroidetes and the Firmicutes "Bad digestion is the root of all evil" Hippocrates, 400 B.C. Sekirov I, et al. Physiol Rev 2010;90:839-904 4

Dysbiosis Intestinal bacterial overgrowth Disruption of tight junction proteins Bacterial products (LPS) Hepatic inflammation Fibrosis progression Insulin resistance Steatosis Bacterial translocation "LEAKY GUT" Adapted from Sekirov I, et al. Physiol Rev 2010;90:839-904 (Ratio optimized to extract energy from food) metabolic stress "Metabolic infection" Adapted from Moschen AR, et al. Trends in Endocrinology and Metabolism 2013;24:537-45 Intestinal microbiota determines the development of NAFLD Hyperglycemia Inflammation High-fat diet Normoglycemia Inflammation Hyperglycemia IR Steatosis Germ-free mices High-fat diet Normoglycemia No IR No steatosis Le Roy T, et al. Gut 2013;62:1878-94 Conclusions Excessive alcohol consumption per se is not sufficient to induce ALD Environmental factors play an important role, mainly being overweight and having a metabolic syndrome Genetic background obvious The best candidate gene is PNPLA3 rs738109 G Targeting the gut microbiota could be a new therapeutic approach for several liver diseases 5